<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01562795</url>
  </required_header>
  <id_info>
    <org_study_id>Xzhou</org_study_id>
    <nct_id>NCT01562795</nct_id>
  </id_info>
  <brief_title>Efficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye Disease</brief_title>
  <official_title>Efficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wenzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wenzhou Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical trial is to investigate whether nonsteroid anti-inflammatory drops have
      therapeutic effect on moderate to severe dry eye patients.And compare the efficacy of the two
      nonsteroid anti-inflammatory drops with topical corticosteroids.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">July 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>tear osmolarity</measure>
    <time_frame>Day 0, Day 14</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>corneal staining</measure>
    <time_frame>0 day,7th day and 14th day after treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Schirmer test(without anaesthesia)</measure>
    <time_frame>0 day,7th day,14th day after treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tear film breakup time(TBUT)</measure>
    <time_frame>0 day,7th day and 14th day after treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>meibomian gland function</measure>
    <time_frame>0 day,7th day and 14th day after treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Moderate to Severe Dry Eye Syndrome</condition>
  <arm_group>
    <arm_group_label>group 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>group 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>group 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>group 4</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>nonsteroid anti-inflammatory drops</intervention_name>
    <description>nonsteroid anti-inflammatory drops plus artificial tear substitute</description>
    <arm_group_label>group 1</arm_group_label>
    <other_name>prunoprefen</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>nonsteroid anti-inflammatory drops</intervention_name>
    <description>nonsteroid anti-inflammatory drops plus artificial tear substitute</description>
    <arm_group_label>group 2</arm_group_label>
    <other_name>bronuck</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>corticosteroids</intervention_name>
    <description>corticosteroids plus artificial tear substitute</description>
    <arm_group_label>group 3</arm_group_label>
    <other_name>Fluorometholone</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>artificial tear substitute</intervention_name>
    <description>artificial tear substitute alone</description>
    <arm_group_label>group 4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  moderate to severe dry eye syndrome

          -  tear film breakup time ＞0 second and ≤5 seconds,or schirmer test(no
             anaesthesia)≥2mm/5min and ≤5mm/5min

          -  corneal staining≥3 scores

        Exclusion Criteria:

          -  allergic to any composition of the drugs under experiment

          -  previous use of anti-inflammatory drugs or immunosuppressive agent

          -  viral,bacterial or fungal infection of the eye

          -  eyelid anomaly

          -  glaucoma or high IOP

          -  significant meibomian gland dysfunction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wei Chen, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Eye Hospital, Wenzhou Medical College, China</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Eye Hospital, Wenzhou Medical College</name>
      <address>
        <city>Wenzhou</city>
        <state>Zhejiang</state>
        <zip>325027</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 22, 2012</study_first_submitted>
  <study_first_submitted_qc>March 23, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2012</study_first_posted>
  <last_update_submitted>January 2, 2014</last_update_submitted>
  <last_update_submitted_qc>January 2, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 3, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wenzhou Medical University</investigator_affiliation>
    <investigator_full_name>Xiangtian Zhou</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
    <mesh_term>Dry Eye Syndromes</mesh_term>
    <mesh_term>Eye Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Inflammatory Agents</mesh_term>
    <mesh_term>Fluorometholone</mesh_term>
    <mesh_term>Lubricant Eye Drops</mesh_term>
    <mesh_term>Anti-Inflammatory Agents, Non-Steroidal</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

